A Revolutionary Platform for Drug Discovery
GigaGen’s high-throughput single cell sequencing and protein expression platform uses microfluidics, bioinformatics, next generation sequencing, and genetic engineering to mine B and T cell repertoires for full length natively paired antibodies and T cell receptors (TCRs), revolutionizing the traditional drug discovery process.
Our platform integrates cell clonal identity, function, and target binding across millions of single primary B or T cells in parallel, creating libraries of antibodies or T cell receptors to express or sequence at a rate of millions per hour, eclipsing conventional methods by several orders of magnitude.
For the first time ever, GigaGen understands the immune response to disease with incredible breadth and detail, and is now using its power to create lifesaving therapies. No other technology pairs massively parallel sequencing with millions-diverse protein expression.